Kinnate Biopharma Inc (DELISTED) (KNTE:DL)
2.65
0.00 (0.00%)
USD |
NASDAQ |
Apr 03, 16:00
Kinnate Biopharma Cash from Operations (TTM): -100.04M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -100.04M |
| September 30, 2023 | -106.43M |
| June 30, 2023 | -101.55M |
| March 31, 2023 | -95.67M |
| December 31, 2022 | -89.03M |
| September 30, 2022 | -87.81M |
| June 30, 2022 | -84.79M |
| Date | Value |
|---|---|
| March 31, 2022 | -78.71M |
| December 31, 2021 | -71.06M |
| September 30, 2021 | -62.32M |
| June 30, 2021 | -52.70M |
| March 31, 2021 | -40.95M |
| December 31, 2020 | -30.18M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-106.43M
Minimum
Sep 2023
-30.18M
Maximum
Dec 2020
-77.02M
Average
-84.79M
Median
Jun 2022
Cash from Operations (TTM) Benchmarks
| XOMA Corp | -18.16M |
| Societal CDMO Inc (DELISTED) | -1.005M |
| NGM Biopharmaceuticals Inc (DELISTED) | -132.20M |
| Avrobio Inc | -63.19M |
| Landos Biopharma Inc | -20.48M |